New Dosing Regimen Approved for Erbitux in Colorectal, Head and Neck Cancer
The new dosing schedule is in addition to the approved weekly dosage regimen.
Oncology
Chemotherapy-Induced Nausea and Vomiting Guidelines: Prophylaxis
The ASCO guideline provides updated recommendations for the prevention and management of chemotherapy-induced nausea and vomiting (CINV) based on the emetic risk of the treatment regimen.
Effects of Drugs Targeting Mitochondrial Respiration in Melanoma
Despite relying on glycolysis, there is growing evidence that many tumor types still have high levels of mitochondrial energy metabolism and functioning oxidative phosphorylation. One such subset of tumors is melanoma, potentially playing a role in both tumor progression and resistance to therapy. This has led researchers to wonder whether targeting mitochondrial respiration could be…
How Can Disparities in Lung Cancer Screening Eligibility Be Addressed?
A significant amount of progress has been made in improving the treatment of lung cancer and patient outcomes. However, a number of disparities that can have an impact on these persist, including those affecting lung cancer screening. Lung cancer screening is an essential step toward effective treatment and improved survival, but its success depends on…
Can the Type of Breast Cancer Surgery Affect Psychosocial Health in Young Patients?
Breast cancer is an incredibly fraught experience for patients. Even beyond the diagnosis and treatment, the experience can create emotional issues that linger long after remission. Patients can have issues related to body image that can dramatically affect their self-esteem and sexuality as they work to regain a sense of normality in their daily lives.…
Can Earlier Mammographic Screenings Affect Mortality Rates?
When should women begin getting mammograms? Guidance can vary based on an individual’s family history or other high-risk identifiers, but physicians advise that women get screened for breast cancer consistently by at least age 50. However, a recent study out of the United Kingdom suggests that starting breast cancer screenings earlier could have a large…
Opdivo Approved for Advanced Esophageal Squamous Cell Carcinoma
The FDA has approved Opdivo® (nivolumab; Bristol Myers Squibb) for the treatment of patients with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma (ESCC) after prior fluoropyrimidine- and platinum-based chemotherapy.
Fertility Treatment and Childhood Cancer Risk: What’s the Link?
Of all types of fertility treatment examined, the only one that significantly increased the risk of cancer in children was frozen embryo transfer.
Antiemetic Treatments
Antiemetic treatment chart including drug formulations, strengths, and usual doses for nausea/vomiting.
Cancer Risk From Recalled ARBs “Likely Much Lower” Than Initially Estimated, Says FDA
The FDA is working in close collaboration with global regulatory partners to evaluate the controls in place and publish guidance on preventing unacceptable levels of nitrosamine in drugs.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...